New achievements in the realm of nanoscience and innovative techniques of nanomedicine
have moved micro/nanoparticles (MNPs) to the point of becoming actually useful for …

Highlights•Traditional drug screening model systems are inadequate.•Organoid-on-a-chip
platforms stand to significantly advance drug and toxicology screening.•A wide variety or …

Significant advances in biomaterials, stem cell biology, and microscale technologies have
enabled the fabrication of biologically relevant tissues and organs. Such tissues and organs …

Microfluidic technologies employ nano and microscale fabrication techniques to develop
highly controllable and reproducible fluidic microenvironments. Utilizing microfluidics, lead …

Novel microfluidic tools allow new ways to manufacture and test drug delivery systems.
Organ-on-a-chip systems—microscale recapitulations of complex organ functions—promise …

The implementation of microfluidic devices within life sciences has furthered the possibilities
of both academic and industrial applications such as rapid genome sequencing, predictive …

Amorphous silica nanoparticle (SiNPs) has tremendous potential for a host of applications,
while its mass production, broad application and environmental release inevitably increase …

The alignment of anisotropic nanoparticles in flow has been used for a range of applications
such as the preparation of strong fibres and the assembly of in‐plane aligned 1D …

Silica nanoparticles (SiNPs) are being explored as nanocarriers for therapeutics delivery,
which can address a number of intrinsic drawbacks of therapeutics. To translate laboratory …

Nanomaterials can get into the blood circulation after injection or by release from implants
but also by permeation of the epithelium after oral, respiratory or dermal exposure. Once in …